Alzheimer’s/Dementia

Benzos may impact Alzheimer’s lifespan

Benzodiazepines, prescribed to lessen insomnia and anxiety, may be associated with an earlier death in those with Alzheimer’s disease.

Read More >>

2017 OPTIMA Award: The power of No

The winner of the 2017 OPTIMA Award for Excellence in Memory Care has slashed its use of antipsychotics to just 3 percent by retraining its staff and implementing a strict “just say no” policy. Read More >>

Refusing to be spoon-fed

A Washington state agency has drafted guidelines for people with dementia who don’t want to receive oral foods or fluids. 

Read More >>

Bill Gates invests $100M toward Alzheimer’s treatments

Gates is investing his own fortune toward dementia research and startups exploring new treatments.

Read More >>

Healthcare isn’t ready for Alzheimer’s treatments, study finds

Administering dementia treatments may be more difficult than developing them, according to a RAND report on healthcare infrastructure. 

Read More >>

Personalized doors help residents with dementia to find their way

Door decals are giving a Canadian memory care facility a new look and helping residents with wayfinding and navigation.

Read More >>

AARP Foundation sues to stop nursing home evictions

The organization is taking up its first court case on behalf of a woman with Alzheimer’s who was discharged from her nursing home without warning.

Read More >>

Shopping for good

 A Virginia resale boutique pledged $125k toward a memory care retrofit at an area senior living facility.

Read More >>

Dementia rises to No. 1 killer in Britain

Advocacy groups say the government’s £132 million funding for Alzheimer’s research needs to be doubled for at least the next five years.

Read More >>

A new approach for treating Parkinson’s psychosis

Recent findings offer more support for primavanserin, an antipsychotic that works more effectively than other widely-used drugs—and without the damaging side effects. 

Read More >>